News Related to Advanced Pancreatic Cancer

Related coverage linked through entity extraction aliases.

Experimental Pill Daraxonrasib Nearly Doubles Survival in Advanced Pancreatic Cancer Trial

Jun 01, 2026

An experimental pill called daraxonrasib nearly doubled survival for patients with advanced pancreatic cancer in a clinical trial, marking a significant advance for a deadly disease. The drug targets a mutated protein previously considered "undruggable" and reduced the risk of death by 60% compared to chemotherapy.

Pancreatic Cancer Precision Medicine Market to Reach $2.5 Billion by 2033

Feb 17, 2026

The global pancreatic cancer precision medicine market is projected to grow from US$ 610 million in 2024 to US$ 2,467.83 million by 2033 at a 16.8% CAGR, driven by advances in targeted therapies, genomic diagnostics, and liquid biopsies.